Literature DB >> 18493733

[Brain tumors in childhood].

M Sinzig1, J Gasser, B Jauk, K A Hausegger.   

Abstract

Central nervous system (CNS) tumors are the most common solid neoplasms in childhood and the second most common malignancies after leukemia in the pediatric age group. Supratentorial tumors are more common in children younger than 2 years old and in adolescents, whereas in patients between 2 and 12 years of age brain tumors originating in the posterior fossa dominate. This implies a relationship between the type of tumor, its location and the age of the patient, which has to be considered in differential diagnoses. Medulloblastoma represents the most common malignant brain tumor in childhood. In the posterior fossa medulloblastomas are approximately as frequent as astrocytomas. Supratentorial astrocytomas are by far the main tumor type. In this report some typical CNS neoplasms in children are discussed and their neuroradiological features are demonstrated.

Entities:  

Mesh:

Year:  2008        PMID: 18493733     DOI: 10.1007/s00117-008-1649-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  29 in total

1.  Changes in cerebral cortex of children treated for medulloblastoma.

Authors:  Arthur K Liu; Karen J Marcus; Bruce Fischl; P Ellen Grant; Tina Young Poussaint; Michael J Rivkin; Peter Davis; Nancy J Tarbell; Torunn I Yock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-26       Impact factor: 7.038

2.  Posterior fossa lateral ependymoma in childhood.

Authors:  M G Nagib; M T O'Fallon
Journal:  Pediatr Neurosurg       Date:  1996-06       Impact factor: 1.162

3.  Infratentorial pediatric brain tumors: the value of new imaging modalities.

Authors:  J F Schneider; A Viola; S Confort-Gouny; K Ayunts; Y Le Fur; P Viout; M Bennathan; F Chapon; D Figarella-Branger; P Cozzone; N Girard
Journal:  J Neuroradiol       Date:  2007-03       Impact factor: 3.447

4.  Primary cerebellar glioblastomas multiforme in children. Report of four cases.

Authors:  A V Kulkarni; L E Becker; V Jay; D C Armstrong; J M Drake
Journal:  J Neurosurg       Date:  1999-03       Impact factor: 5.115

5.  Intra-axial tumors of the cervicomedullary junction.

Authors:  F Epstein; J Wisoff
Journal:  J Neurosurg       Date:  1987-10       Impact factor: 5.115

6.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.

Authors:  L B Rorke; R Packer; J Biegel
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Benign cerebellar astrocytomas in children.

Authors:  P Pencalet; W Maixner; C Sainte-Rose; A Lellouch-Tubiana; G Cinalli; M Zerah; A Pierre-Kahn; E Hoppe-Hirsch; M Bourgeois; D Renier
Journal:  J Neurosurg       Date:  1999-02       Impact factor: 5.115

8.  Brain tumors in children: long-term survival after radiation treatment.

Authors:  D Jenkin; M Greenberg; H Hoffman; B Hendrick; R Humphreys; A Vatter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-02-01       Impact factor: 7.038

9.  Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.

Authors:  C Daumas-Duport; B W Scheithauer; J P Chodkiewicz; E R Laws; C Vedrenne
Journal:  Neurosurgery       Date:  1988-11       Impact factor: 4.654

10.  Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas.

Authors:  K Ikezaki; T Matsushima; T Inoue; N Yokoyama; Y Kaneko; M Fukui
Journal:  Neurosurgery       Date:  1993-01       Impact factor: 4.654

View more
  2 in total

1.  EGF as a New Therapeutic Target for Medulloblastoma Metastasis.

Authors:  Jennifer Rico-Varela; Tanya Singh; Sean McCutcheon; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2015-06-04       Impact factor: 2.321

2.  Psychological Needs and Resources of the Staff in a Pediatric Neurosurgery Ward: A Phenomenological-Hermeneutic Study.

Authors:  Iacopo Lanini; Debora Tringali; Rosapia Lauro Grotto
Journal:  Front Psychol       Date:  2022-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.